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Abstract: Ricin is a heterodimeric plant protein that is potently toxic to mammalian and 
many other eukaryotic cells. It is synthesized and stored in the endosperm cells of maturing 
Ricinus communis seeds (castor beans). The ricin family has two major members, both, 
lectins, collectively known as Ricinus communis agglutinin ll (ricin) and Ricinus communis 
agglutinin l (RCA). These proteins are stored in vacuoles within the endosperm cells of 
mature Ricinus seeds and they are rapidly broken down by hydrolysis during the early 
stages of post-germinative growth. Both ricin and RCA traffic within the plant cell from 
their site of synthesis to the storage vacuoles, and when they intoxicate mammalian cells 
they traffic from outside the cell to their site of action. In this review we will consider both 
of these trafficking routes. 
Keywords:  ricin  biosynthesis;  anterograde  transport;  retrograde  transport;  endoplasmic 
reticulum; retrotranslocation 
 
1. Introduction 
Ricin and RCA are galactose-specific lectins, each possessing at least two sugar binding sites. Ricin 
was, in fact, the first lectin to be described well over a century ago [1]. Stillmark, a PhD student at the 
University of Dorpat in Estonia, was looking for an explanation for the well known toxicity of Ricinus 
seed extracts. He studied the effects of mixing seed extract with blood and observed that the red blood 
cells began to agglutinate. He established that the active seed component was a protein which he 
termed ricin. We now know that the agglutination he observed is largely due to RCA, which is a  
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strong haemagglutinin but a weak cytotoxin, whereas ricin is a weak haemagglutinin but is potently  
cytotoxic [2,3]. This results from ricin having a single B chain, enabling it to bind to and enter target 
cells, whereas RCA has two B chains allowing it to bind to, and thus agglutinate, two target cells. 
Ricin is a heterodimer in which a catalytically-active A chain (ricin toxin A or RTA) is joined by a 
single disulfide bond to a B chain (RTB) that is a galactose- and N-acetylgalactosamine-specific lectin. 
The A chain is an enzyme that removes a specific adenine residue from the 28S ribosomal RNA 
(28SrRNA) of the large subunit of eukaryotic ribosomes [4]. The adenine residue removed by RTA, 
adenine 4324 in the case of rat liver 28SrRNA, is located in a region of the rRNA that contains one of 
the most conserved of rRNA sequences. This region functions in the ribosomal elongation cycle, and 
the adenine removed as a result of RTA-catalysed depurination is the binding site for elongation factors 
1 and 2 [5]. Since RTA-modified ribosomes are unable to bind these translation factors they are no 
longer capable of continuing protein synthesis. This ultimately leads to cell death and accounts for the 
extreme cytotoxicity of ricin [6–8]. RCA is a tetramer of two ricin-like heterodimers, each of which 
consists of an A and a B chain. The primary sequence of the A chains of ricin and RCA are identical in 
all but 18 positions (from a total of 267 amino acids) and are thus 93% homologous. The corresponding 
B chains differ at 41 residues (from a total of 262 residues) and are 84% homologous [9,10]. Two of the 
18 residue differences between RTA and RCA A chain involve the substitution of cysteine residues, 
one of which (Cys156) forms  a disulfide bond with  an adjacent  molecule to  generate the mature 
~128 kDa tetrameric RCA with the subunit arrangement B-A-A-B [11,12]. 
2. Ricin Trafficking In Plant Cells 
2.1. Ricin Biosynthesis 
Ricin and RCA are synthesized in the seeds at the developmental stage when seed storage proteins 
are being synthesized and, like these storage proteins, the lectins are located in the storage vacuoles of 
the  mature  seed  [13,14].  Lectin  and  storage  protein  synthesis  is  therefore  both  developmentally 
regulated and tissue specific, with synthesis occurring exclusively in the endosperm cells of maturing 
seeds [15]. Here they accumulate in protein storage vacuoles until, at seed dessication, the lectins 
account  for  approximately  5%  of  the  total  particulate  protein  [13,14].  The  storage  proteins  are 
hydrolysed during the first few days after germination to provide a source of amino acids for the 
synthesis of proteins encoded by genes that are expressed at this stage of seedling development. After 
a few days of post-germinative growth, the stored protein reserves, including ricin and RCA, have 
disappeared entirely as the developing plant is increasingly able to synthesize the amino acids it needs 
via photosynthesis. The ricin gene family (which includes both ricin and RCA) has been reported to 
contain  6–8  members,  as  detected  by  Southern  blot  analysis  using  ricin  cDNA  probes  [16,17]. 
However, the recently  reported draft  genome sequence of  Ricinus  communis  revealed 28 putative 
genes in the family, including potential pseudogenes or gene fragments, but only one copy of the gene 
set responsible for castor oil biosynthesis, suggesting that there is a selective pressure for the seeds to 
produce a highly toxic protein [18]. The biological function of ricin therefore appears to be as a seed 
storage protein, presumably with the added advantage that its potent toxicity deters herbivores from 
eating the seeds. Toxins 2011, 3              
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2.2. Synthesis and Endoplasmic Reticulum Translocation 
Heterodimeric ricin is initially synthesized as a single chain polypeptide precursor (preproricin) 
containing both the RTA and RTB sequences [9]. Preproricin contains 576 amino acid residues, the 
first 35 of which encode a 26 residue N-terminal signal sequence and a 9 residue propeptide [19], 
followed by the mature RTA sequence (267 residues) joined by a 12 residue linker peptide to the 
mature RTB sequence (262 residues). The 12 residue linker peptide contains a targeting signal that 
directs the ricin precursor to the vacuole [20]. During synthesis in the plant cell, the N-terminal signal 
sequence  directs  the  transport  of  the  nascent  polypeptide  across  the  endoplasmic  reticulum  (ER) 
membrane and into the ER lumen, leaving the 9 residue propeptide exposed at the N-terminus.  
Translocation  across  the  ER  membrane  is  accompanied  by  three  major  modifications.  First,  the  
N-terminal  signal  sequence  is  co-translationally  cleaved  by  ER  luminal  signal  peptidase.  Second, 
proricin is N-glycosylated as it enters the ER lumen. Proricin has four N-glycosylation sites, two within 
the RTA sequence and a further two in RTB  [21]. Third, protein disulfide isomerase  catalyses  the 
formation of five disulfide bonds in the folding protein. In mature ricin, four of these disulfide bonds are 
within RTB, while the fifth one is the disulfide linking RTA to RTB. The individual heterodimers that 
constitute RCA are synthesised as preproRCA in an identical manner to preproricin [10] but, as noted 
above, RCA contains an additional disulfide bond that links two heterodimers to form a tetramer [11]. 
The 9 residue propeptide at the N-terminus of RTA after cleavage of the signal peptide acts as a 
spacer that influences the efficiencies of both co-translational transport across the ER membrane and 
core  glycosylation  [22].  Newly  synthesized  proricin  in  the  ER  lumen  lacks  the  26  residue  signal 
peptide, which was cleaved co-translationally, but still includes the  N-terminal propeptide and the  
12 residue linker peptide. This is probably important for the producing plant whose own ribosomes are 
susceptible to the action of RTA [23], because the RTA moiety of proricin, in contrast to free RTA, is 
catalytically inactive [24]. Association with the B chain inhibits the catalytic activity of the A chain. 
This  inactivity  results  from  a  steric  hindrance  of  the  RTA  active  site  by  RTB  in  the  proricin  
precursor [24]. Indeed, this inhibition of the RTA active site by RTA:RTB coupling persists in the 
mature heterodimer [25]. Since ricin is produced, transported and stored as a catalytically-inactive 
form, should any precursor be inefficiently or incompletely imported the hindered active site would 
prevent ribosome inactivation. 
2.3. Anterograde Trafficking in the Plant Cell 
Glycosylated proricin is transported in vesicular carriers from the ER, via the Golgi complex, to the 
vacuole. The attached glycans are modified during intracellular transport [21,26] and, upon reaching the 
vacuole, proricin is processed by an endopeptidase that removes the 12 residue linker sequence between 
RTA and RTB, and the 9 residue N-terminal propeptide [21]. The vacuolar processing enzyme (VPE) 
responsible for cleaving proricin does so on the C-terminal side of asparagine residues. Both of the 
peptides  removed  from  proricin  terminate  in  asparagine.  This  type  of  proteolysis  is  typical  in  the 
maturation of seed storage proteins [27–29]. VPE has also been identified as a caspase involved in 
vacuole-mediated cell death [30]. RTA and RTB are still covalently joined by a disulfide bond because Toxins 2011, 3              
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cleavage of the linker occurs within a disulfide loop connecting the A and B chain sequences [31]. The 
biosynthesis and intracellular transport of ricin in Ricinus cells is illustrated schematically in Figure 1. 
Figure 1. Biosynthesis and intracellular trafficking of ricin and its precursors in Ricinus 
endosperm cells. SS, signal sequence; P, propeptide; L, linker peptide; orange bracket, 
interchain disulfide; gray  brackets, intrachain disulfides. Also shown is the ricin X-ray 
structure and a cartoon showing the arrangement of the chains and the position of the 
interchain disulfide bond. 
 
The ricin biosynthetic events in Ricinus endosperm have been recapitulated in tobacco protoplasts 
using transient expression and metabolic labelling  [32]. This provided the first indication that the  
12 residue linker peptide contained the vacuolar sorting signal. The linker peptide contains the amino 
acid sequence LLIRP, which is reminiscent of the sequence specific vacuolar sorting signal NPIRL 
found in proteins such as sweet potato sporamin [33] and barley aleurain [34]. Replacing the isoleucine 
of this sequence with glycine resulted in the complete secretion of proricin [20]. 
3. Ricin Trafficking in Mammalian Cells 
In order to reach its ribosomal target in mammalian cells, free RTA must ultimately be delivered into 
the cytosol of such cells. RTA, in common with the catalytic moieties of several other protein toxins, is 
believed to achieve the ultimate step of entry into the cytosol from the lumen of the ER by subverting a Toxins 2011, 3              
 
791 
quality control process in the ER known as ER-associated protein degradation (ERAD) [35]. Before 
discussing how this is thought to be achieved, here is a brief description of the current understanding of 
the process of ERAD. 
In eukaryotic cells, the ER is the site of entry for proteins destined for the secretory pathway or for 
insertion into the membranes of organelles involved in this pathway. The nascent proteins enter the ER 
lumen via the Sec61 translocon present  in  the ER  membrane  [36].  In the ER  lumen these newly 
synthesised  proteins  fold  and  mature,  processes  that  depend  on  ER  chaperones  and  may  include  
ER-located  enzymes  that  catalyse  core  N-glycosylation  or  disulfide  bond  formation.  Oligomeric 
proteins  are  also  assembled  from  their  monomeric  constituents.  The  fidelity  of  these  processes  is 
monitored by an ER quality control (ERQC) surveillance. Newly synthesised proteins that fold or 
assemble correctly are permitted by ERQC to remain in the ER (if this compartment is their ultimate 
destination)  or  to  exit  the  ER  in  vesicular  carriers  if  destined  for  post-ER  compartments  or  for 
secretion from the cell. Proteins that fail to fold or assemble correctly are recognized as such and 
disposed of, since their accumulation in the cell would be detrimental. Such proteins are disposed of by 
the aspect of ERQC known as ERAD [37]. 
ERAD involves multiple disposal processes which remove the aberrant proteins from the ER by 
directing them to the cytosolic proteasomes for proteolytic degradation [38]. Removal from the ER 
(known as retrotranslocation or dislocation) requires ER membrane ubiquitin ligase complexes that 
polyubiquitylate the target ERAD substrates as they are extruded through the ‘dislocon’ to enter the 
cytosol [39,40]. Polyubiquitylation targets the ERAD substrates to the AAA-ATPase p97 (Cdc48 in 
yeast) complex that is the extraction motor [41–44] that delivers them to the proteasome [45,46]. If the 
dislocated  proteins  are  glycosylated,  they  are  de-glycosylated,  and  all  ERAD  substrates  are  
de-ubiquitylated before being destroyed by proteasomal degradation [38]. 
Complete destruction of ERAD substrates by the proteasome does not appear to be an unavoidable 
event, and a few ER-located proteins appear to subvert ERAD by uncoupling, at least in part, from the 
final destructive step. For example, the human hepatitis E virus ORF2 protein is initially present in the 
ER but it subsequently appears in the cytosol, where it refolds rather than being degraded [47]. Firefly 
and Renilla luciferases internalized by dendritic cells are thought to traffic in vesicular structures to 
reach  the  ER  where  they  unfold  to  subvert  ERAD  and  subsequently  refold  after  reaching  the  
cytosol [48]. In addition, calreticulin, normally a resident protein of the ER, has been identified in the 
mammalian cell cytosol. This cytosolic population has  apparently been derived from the ER, and 
appears to have been dislocated by ERAD in a non-ubiqutylated manner and then refolded, rather than 
being completely degraded, in the cytosol [49]. Thus certain proteins can uncouple from the final 
degradative step of ERAD. Protein toxins that retrotranslocate from the ER are believed to represent 
another family of proteins that fall into this category [35]. 
3.1. Ricin Entry into Mammalian Cells 
Ricin, in common with other A-B family plant and bacterial toxins, enters mammalian cells by 
endocytosis after binding to cell surface components that inadvertently act as toxin receptors. In the 
case of ricin, which is a galactose-specific lectin, potential surface targets are all components with Toxins 2011, 3              
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exposed β-1,4-linked galactose residues. Such components are typically abundant on mammalian cells 
(HeLa cells, for example, contain 3 ×  10
7 potential ricin binding sites [50]). 
Some of the surface-bound ricin then enters the cell by endocytosis, the endocytic route utilised  
(e.g.,  clathrin-dependent  or  clathrin-independent  endocytosis)  being  that  followed  by  the  surface 
component to which ricin opportunistically binds. Regardless of the endocytic route taken, the ricin that 
enters the cell is firstly present in early endosomes (EEs). From EEs, several possible fates are available. 
A portion of the ricin in EEs progresses via late endosomes to the lysosome, where it is proteolytically 
degraded. Some of the ricin in EEs enters recycling endosomes and is returned to the cell surface in a 
futile entry-exit cycle. A small portion of the ricin in EEs progresses to the trans-Golgi network (TGN), 
and this is the portion that is critical for cytotoxicity [51,52]. 
The retrograde trafficking pathway [53], which transports cargo from the TGN to the ER, usually 
via the Golgi complex, is the route taken by ricin (and other toxins that enter the target cell cytosol 
from the ER) to reach the ER lumen. In the case of ricin, molecular details of this trafficking step are 
largely unknown at present. The retrograde transport of Shiga toxin (STx) (another A-B toxin believed 
to enter the cytosol from the ER) has received more attention and is currently better understood [53,54]. 
It was originally assumed that ricin would use the same or similar components to those used by STx to 
achieve retrograde trafficking to the ER. However, recent studies are revealing differences, not in the 
ultimate destination of the retrograde pathway (namely, the ER), but in the molecular details of how 
different toxins are transported. A good example of this is shown by the comparison between the 
bacterial toxins STx and cholera toxin (CTx), both of which are eventually delivered to the ER. The 
small molecule Exo2, an inhibitor of a subset of Arf-GEF functions [55] strongly blocks egress of STx 
from EEs [56], but has little or no effect on CTx trafficking [57]. Furthermore, the clathrin associated 
Hsc70 co-chaperone RME-8 regulates endosomal trafficking of STx [58], but has no effect on the 
transport of CTx [59]. 
Regardless  of  the  molecular  details  of  the  trafficking  of  individual  toxins,  each  of  the  afore 
mentioned toxins, including ricin, reaches the ER as the final membrane-delimited compartment from 
which entry into the cytosol is achieved. 
3.2. Pre-Dislocation Events in the ER 
Once the ricin holotoxin reaches the ER lumen, RTA must be released so that it can retrotranslocate 
in a potentially catalytically-active conformation. The reductive separation of RTA and RTB is catalysed 
by protein disulfide isomerase [60,61] even in the oxidizing environment of the ER lumen [62]. 
RTA is believed to achieve ER export by subverting ERAD. Polyubiquitylation is a key feature for 
selecting proteins for proteasomal degradation, and the polyubiquitin chains are normally added to 
lysine  redsidues.  The  catalytic  A  chains  of  toxins  that  enter  the  cytosol  from  the  ER  have  an 
uncharacteristically low lysine content, and Hazes and Read [63] were the first to suggest that this low 
lysine content might allow the proteins to subvert ERAD for ER-to-cytosol transport. Experimental 
support  for  this  contention  in  the  case  of  RTA  has  been  presented  [64].  Introducing  extra  lysine 
residues into RTA increased its propensity for proteasomal degradation by rendering the modified 
RTA  a  better  substrate  for  ubiquitylation  [64].  Supplementing  the  A  chain  of  CTx  with  lysines 
likewise increased the extent of its proteasomal degradation [65]. Toxins 2011, 3              
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How is a native protein like RTA perceived by ERQC to be a substrate for the ERAD process? The 
answer appears to be that RTA partially unfolds in the ER. RTA contains a hydrophobic stretch of 
amino acids close to its C-terminus [9]. In the ricin holotoxin, this hydrophobic region is covered by 
RTB.  When  RTA  is  released  from  the  holotoxin,  this  region  becomes  exposed  allowing  RTA  to 
interact with the ER membrane. The first indication that such an interaction might promote RTA 
unfolding came from the demonstration that RTA did indeed unfold in the presence of liposomes 
containing  a  negatively-charged  phospholipid  [66].  Subsequently  RTA  was  shown  to  unfold  after 
interaction with ER-derived microsomal membranes, with negatively-charged phosphatidylserine the key 
membrane component in this interaction [67]. Furthermore, RTA inserts into the microsomal membrane 
at 37 ° C and, predictably, it is the C-terminal hydrophobic region that enters the membrane [67]. Purified 
RTA is also thermally unstable, forming a molten globule at 45 ° C [68], but even at 37 ° C it is 
relatively unstable and prone to aggregation [69]. 
The driving force for RTA unfolding in the ER lumen appears to be thermal instability of RTA 
released from the ricin holotoxin, coupled with an ordered insertion into the ER membrane that results 
in partial unfolding of the RTA structure. It is speculated that this membrane-embedded form may 
mimic a misfolded protein that can then be dislocated from the ER in an ERAD-like manner. Prior to 
dislocation, ERAD substrates must be maintained in a soluble form, which may provide rationales for 
the requirement of co-chaperones of Bip [69,70], and the finding that the ERAD-specific mannosidase 
EDEM modulates ricin toxicity [71]. 
The A chain of STx also possesses a hydrophobic segment required for its dislocation when 
expressed in yeast ER [72]. A synthetic peptide containing this hydrophobic sequence interacts 
with lipid membranes [73,74]. While it is tempting to speculate that the interaction of STx A chain 
with  membranes  induces  its  partial  unfolding,  as  is  the  case  for  RTA,  this  has  not  yet  been 
experimentally demonstrated.  
3.3. Dislocation from the ER 
RTA dislocation has been examined in Saccharomyces, plant systems and in mammalian cells, 
revealing a number of common aspects, but also showing that there are system-specific requirements. 
RTA  expressed  exogenously  in  yeast  and  directed  to  the  ER,  dislocates  and  regains  an  active 
conformation in the cytosol, inhibiting yeast protein synthesis and causing a severe growth defect [70]. 
We have taken advantage of this, using a yeast library in which each non-essential gene has been 
individually knocked out, to identify gene knock-outs that alleviated this growth defect. 
This  work  demonstrated  that  RTA  does  indeed  subvert  ERAD  for  export  from  the  yeast  ER, 
utilizing the integral membrane HRD E3 ubiquitin ligase complex for dislocation. Although RTA 
dislocation is strongly dependent on the core protein Hrd1p and its regulator Hrd3p, requirements for 
membrane-anchoring subunits of this complex and the accessory factors that optimize its performance 
are intermediate (e.g., Der1p, the yeast homolog of derlin-1) or minor and it is independent of the  
E3 activity of Hrd1p [70], indicating that canonical ubiquitylation does not occur during dislocation. 
Consistent with this, RTA is not extracted from the yeast ER by Cdc48p or its ubiquitin-handling  
co-factors [70]. Rather, the RTA extraction motor appears to be the Rpt4p subunit of the proteasomal 
cap, which had previously been shown to play a role in the extraction of other substrates in conjunction Toxins 2011, 3              
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with Cdc48p [46]. Curiously, dislocated RTA is not degraded by the proteasomal core, at least in yeast, 
even though there is significant degradation of the toxin during pulse-chase experiments [70]. 
Thus RTA appears to be dislocated in yeast promiscuously through non-anchored, non-optimised 
dislocons, and it avoids proteasomal degradation. In marked contrast, a mutant form of RTA that is 
unable to fold into the native conformation acts as a bona-fide ubiquitylated and N-glycosylated ERAD 
substrate that is extracted in a Cdc48-dependent manner, de-glycosylated by peptide N-glycanase [76,77], 
transferred to the proteasome by Rad23p and degraded by the proteasomal core [70]. 
ER  dislocation  of  RTA  in  plant  cells  is  likewise  independent  of  ubiquitylation,  although  there 
appears to be a role for Cdc48 [75], and a proportion is degraded by proteasomes [78]. 
The  RTA  dislocation  process  in  mammalian  cells  has  received  little  attention  to  date.  The 
translocon component Sec61p may be involved [79,80]. A role for the mammalian HRD complex 
regulator  SEL1L  (the  mammalian  equivalent  of  Hrd3p)  has  been  described  for  the  dislocation  of  
RTA [81], suggesting that RTA utilises components of the ERAD machinery to enter the mammalian 
cytosol. However, derlin-1, which is a component of the dislocon in mammalian cells [82,83], does not 
appear to have a role in the dislocation of either RTA [71,81] or the CTx A chain [84] and there 
appears to be a role for the mammalian equivalent of Cdc48, p97 [85]. Furthermore, proteasomal 
inhibition sensitises cells to ricin [64,80] and retards loss of attenuated versions of RTA after direct 
expression in the mammalian ER [81]. 
3.4. Post-Dislocation Events in the Cytosol 
Because RTA co-opts ERAD components by partially unfolding in the ER lumen, it enters the 
cytosol as a misfolded protein and must therefore refold to recover catalytic activity to become active 
against ribosomes. In vitro, RTA unfolded to a molten globule structure recovers catalytic activity in 
the presence of substrate ribosomes [68]. In mammalian cells however post-dislocation scrutiny by the 
cytosolic chaperone Hsc70 is required for RTA refolding [69]. In vitro, Hsc70 can prevent aggregation 
of  heat-denatured  RTA,  so  one  in  vivo  role  for  this  chaperone  could  be  to  aid  the  solubility  of 
dislocated RTA thus allowing it to undergo ribosome-mediated refolding. Alternatively, the role of 
Hsc70  may  be  to  stabilise  RTA  in  the  cytosol  by  masking  the  hydrophobic  region  that  interacts  
with membranes.  
The concentration of Hsc70 co-chaperones in the cytosol modulates the cell’s ability to aid RTA 
refolding,  with  some  (HIP  and  BAG-2)  promoting  toxin  refolding,  while  others  (such  as  the 
proteasome-engaging BAG-1) promote degradation. In addition, there is a sequential chaperone triage 
in the cytosol, where a proportion of RTA is passed, via the Hsc70-Hsp90 organising protein HOP, to 
the Hsp90 chaperone. From here, the net fate of RTA is inactivation, presumably by proteasomal 
degradation.  Although  RTA  is  not  ubiquitylated  during  dislocation,  a  low  level  of  cytosolic 
ubiquitylation  can  occur,  albeit  the  E3  responsible  is  not  yet  known  [70].  In  vitro,  RTA  can  be 
inefficiently ubiquitylated in the presence of Hsc70 and the cytosolic CHIP E3 ubiquitin ligase, and 
this can be improved by mimicking the sequential triage by adding HOP and Hsp90, suggesting that 
the Hsp90 interactions inactivate RTA by stimulating cytosolic ubiquitylation [69]. Thus a network of 
chaperones can determine the fate of RTA in the cytosol by regulating the competing processes of 
refolding and ubiquitin tagging. This may provide a rationale for why the inhibition of proteasomal Toxins 2011, 3              
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degradation slightly sensitises cells to intoxication by ricin, whose toxic subunit is not ubiquitylated 
during its dislocation process [64,80]. Ricin entry and trafficking in mammalian cells is illustrated 
schematically in Figure 2. 
Figure  2.  The  cytotoxic  route  of  ricin  in  mammalian  cells.  After  entering  the  cell  by 
endocytosis,  ricin  traffics  via  vesicular  carriers  through  the  early  endosomes  (EE)  and 
the,trans-Golgi  network (TGN)  to the  ER. ER processing  events include separation  of 
RTA and RTB, interaction of RTA with the ER membrane and likely interactions with 
luminal chaperones prior to dislocation. Post-dislocation triage by cytosolic chaperones is 
thought  to enable a  proportion of the dislocated RTA to refold. PDI, protein disulfide 
isomerise; EDEM, ER degradation enhancing alpha-mannosidase I-like protein; GRP94, 
94 kDa glucose regulated protein. 
 
4. Conclusions 
During its synthesis in the producing plant cells ricin traffics in an anterograde manner from the ER, 
via the Golgi complex, to the vacuole. When it intoxicates mammalian cells this protein undergoes 
retrograde transport from the cell surface to the ER, from where it is translocated into the cytosol. 
Ricin thus crosses the ER membrane twice, from the cytosol to the ER lumen during its synthesis and 
from the lumen to the cytosol as it enters target eukaryotic cells: an interesting and unusual occurrence 
for this interesting and unusual protein. Toxins 2011, 3              
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